title: Application of microarray-based technology to neuroblastoma.
abstract: In the past decade, microarray technology has become a major tool for high-throughput comprehensive analysis of gene expression, genotyping and re-sequencing applications. High-throughput microarrays are used for expression profiling analyses with the aims of gene or pathway discovery, tumor subclassification or relapse risk assessment. The introduction of microarray CGH provides a powerful tool to precisely detect and quantify genomic aberrations and map these directly onto the human genome. This review summarizes the current status of the application of microarray technology to neuroblastoma research.
authors.affiliation: Unit of Translational Paediatric Oncology, National Institute for Cancer Research (IST), Genoa, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Scaruffi
authors.forename: Alexander
authors.initials: A
authors.lastname: Valent
authors.forename: Alexander
authors.initials: A
authors.lastname: Schramm
authors.forename: Kathy
authors.initials: K
authors.lastname: Astrahantseff
authors.forename: Angelika
authors.initials: A
authors.lastname: Eggert
authors.forename: Gian Paolo
authors.initials: GP
authors.lastname: Tonini
mesh_terms: D006801:Humans; D009447:Neuroblastoma / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D020411:Oligonucleotide Array Sequence Analysis